Be sure to check our sister interview main ratings news website

ASX:BNO

Hardman & Co

Bionomics Ltd Third Phase II trial of BNC210 begins

30th May 2018

Bionomics Ltd (ASX:BNO) is an Australian biopharmaceutical company specialising in ion channel drug discovery for central nervous system (CNS) disorders such as anxiety and post-traumatic stress disorder (PTSD). BNO also

Interviews

Vector Capital CEO Agam Jain Discusses Delisting from AIM and Future Growth Plans (VIDEO)
Vector Capital CEO Agam Jain Discusses Delisting from AIM...
Vector Capital (LON:VCAP), a UK-based commercial...
Warpaint London Achieves 75% Profit Surge and Expands Market Reach (VIDEO)
Warpaint London Achieves 75% Profit Surge and Expands Market...
Warpaint London plc (LON:W7L) has reported...
Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO)
Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to...
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman...
Firering Strategic Minerals Expands Resource Potential: An Interview with Vassilios Carellas (VIDEO)
Firering Strategic Minerals Expands Resource Potential: An Interview with...
Firering Strategic Minerals plc (LON:FRG) Independent...
Pulsar Helium Inc. Building a New Era in the Helium Market (VIDEO)
Pulsar Helium Inc. Building a New Era in the...
Pulsar Helium Inc (TSXV:PLSR) a leading...

Funds

TEAM plc announces continued outperformance and expansion of MPS solutions
TEAM plc announces continued outperformance and expansion of MPS solutions
Chinese stocks set for potential boost as US Federal Reserve prepares rate cut
Chinese stocks set for potential boost as US Federal Reserve prepares rate cut
Emerging market assets rally as US dollar dives
Emerging market assets rally as US dollar dives
Business sentiment remains positive among Japanese firms
Business sentiment remains positive among Japanese firms
European stocks rise to two-week high amid anticipation of Fed’s monetary easing
European stocks rise to two-week high amid anticipation of Fed’s monetary easing
Japan’s economic turnaround in 2024
Japan’s economic turnaround in 2024

Presentations

Pennant International Maximising operational efficiency
Pennant International Maximising operational efficiency
Pennant International Group (LON:PEN) CEO Phil...
Norcros Results Year ended 31 March 2024, Strategic Success and Sustainable Growth
Norcros Results Year ended 31 March 2024, Strategic Success...
This Norcros plc (LON:NXR) presentation with CEO...
SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO
SAE Renewables Future Strategy to 2035 and Investment Case...
SAE Renewables Limited (LON:SAE) Chief Executive...
One Health Group (AQSE:OHGR) final results presentation
One Health Group (AQSE:OHGR) final results presentation
One Health Group (AQSE:OHGR) final results...
Cerillion CEO & CFO present stellar H1 2024 interim results
Cerillion CEO & CFO present stellar H1 2024 interim...
Cerillion plc (LON:CER) Interim results presentation...

Broker Talk

Volta Finance: Robust returns and discounted value highlight investment opportunity
Volta Finance: Robust returns and discounted value highlight investment opportunity
Shield Therapeutics: Strong H1 ’24 Sales and Cashflow Outlook for H2 ’25
Shield Therapeutics: Strong H1 ’24 Sales and Cashflow Outlook for H2 ’25
City of London Investment Company sees positive growth in Q4 and FY24 FUM
City of London Investment Company sees positive growth in Q4 and FY24 FUM
Expertise and strategic asset management in an under-supplied market
Expertise and strategic asset management in an under-supplied market
Global perspective and market positioning of pawnbroking for H&T Group
Global perspective and market positioning of pawnbroking for H&T Group
Duke Capital: Record cashflows, High dividend yield and Growth potential
Duke Capital: Record cashflows, High dividend yield and Growth potential

© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.